0 items USD 0.00Search
Your search for "globaldata community acquired infections global clinical trials review h1 2019" gave back 48391 results.
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size is projected to grow from US$ 4644.7 million in 2022 to US$ 6755.7...
Catalog:
LPI
April 2023
Price: USD 3,660.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size was valued at USD 4885.5 million in 2022 and is forecast to a...
Catalog:
GIR
May 2023
Price: USD 3,480.00
The global Hospital-acquired Urinary Tract Infection Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Community Acquired Bacterial Pneumonia(CABP) Therapeutics market size is expected to reach $ 6907.4 million by 2029, rising at a market...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Clinical trial patient recruitment companies use a range of methods, from digital advertising to community partnerships, to find the right patients...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Linezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Hospital-Acquired Pneumonia (HAP) Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Hospital Acquired Pneumonia Drugs market size was valued at US$ 2746.4 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
March 2024
Price: USD 3,660.00
